select search filters
briefings
roundups & rapid reactions
Fiona fox's blog
Speakers:
Prof David Nutt, Chair in Neuropsychopharmacology, Imperial College London
Prof Guy Goodwin, Professor of Psychiatry, University of Oxford
A new report by the European College of Neuropsychopharmacology (ECNP) explored the implications of the withdrawal by major pharmaceutical companies from research into mental disorders and diseases of the brain.